Literature DB >> 19346516

Polymeric osteopontin employs integrin alpha9beta1 as a receptor and attracts neutrophils by presenting a de novo binding site.

Norihisa Nishimichi1, Fumiko Higashikawa, Hiromi H Kinoh, Yoshiko Tateishi, Haruo Matsuda, Yasuyuki Yokosaki.   

Abstract

Osteopontin (OPN) is a cytokine and ligand for multiple members of the integrin family. OPN undergoes the in vivo polymerization catalyzed by cross-linking enzyme transglutaminase 2, which consequently increases the bioactivity through enhanced interaction with integrins. The integrin alpha9beta1, highly expressed on neutrophils, binds to the sequence SVVYGLR only after intact OPN is cleaved by thrombin. The SVVYGLR sequence appears to be cryptic in intact OPN because alpha9beta1 does not recognize intact OPN. Because transglutaminase 2-catalyzed polymers change their physical and chemical properties, we hypothesized that the SVVYGLR site might also be exposed on polymeric OPN. As expected, alpha9beta1 turned into a receptor for polymeric OPN, a result obtained by cell adhesion and migration assays with alpha9-transfected cells and by detection of direct binding of recombinant soluble alpha9beta1 with colorimetry and surface plasmon resonance analysis. Because the N-terminal fragment of thrombin-cleaved OPN, a ligand for alpha9beta1, has been reported to attract neutrophils, we next examined migration of neutrophils to polymeric OPN using time-lapse microscopy. Polymeric OPN showed potent neutrophil chemotactic activity, which was clearly inhibited by anti-alpha9beta1 antibody. Unexpectedly, mutagenesis studies showed that alpha9beta1 bound to polymeric OPN independently of the SVVYGLR sequence, and further, SVVYGLR sequence of polymeric OPN was cryptic because SVVYGLR-specific antibody did not recognize polymeric OPN. These results demonstrate that polymerization of OPN generates a novel alpha9beta1-binding site and that the interaction of this site with the alpha9beta1 integrin is critical to the neutrophil chemotaxis induced by polymeric OPN.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19346516      PMCID: PMC2685658          DOI: 10.1074/jbc.M901515200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

Review 1.  Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival.

Authors:  D T Denhardt; M Noda; A W O'Regan; D Pavlin; J S Berman
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

2.  Tissue transglutaminase and its substrates in bone.

Authors:  Mari T Kaartinen; Sherif El-Maadawy; Niina H Räsänen; Marc D McKee
Journal:  J Bone Miner Res       Date:  2002-12       Impact factor: 6.741

Review 3.  Transglutaminases: crosslinking enzymes with pleiotropic functions.

Authors:  Laszlo Lorand; Robert M Graham
Journal:  Nat Rev Mol Cell Biol       Date:  2003-02       Impact factor: 94.444

4.  The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin.

Authors:  Y Yokosaki; N Matsuura; T Sasaki; I Murakami; H Schneider; S Higashiyama; Y Saitoh; M Yamakido; Y Taooka; D Sheppard
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

5.  Osteopontin, a substrate for transglutaminase and factor XIII activity.

Authors:  C W Prince; D Dickie; C L Krumdieck
Journal:  Biochem Biophys Res Commun       Date:  1991-06-28       Impact factor: 3.575

6.  Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin).

Authors:  R Agnihotri; H C Crawford; H Haro; L M Matrisian; M C Havrda; L Liaw
Journal:  J Biol Chem       Date:  2001-05-25       Impact factor: 5.157

7.  Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases.

Authors:  Hongyan Diao; Shigeyuki Kon; Kazuya Iwabuchi; Chiemi Kimura; Junko Morimoto; Daisuke Ito; Tatsuya Segawa; Masahiro Maeda; Junji Hamuro; Toshinori Nakayama; Masaru Taniguchi; Hideo Yagita; Luc Van Kaer; Kazunori Onóe; David Denhardt; Susan Rittling; Toshimitsu Uede
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

8.  Determination of LOX-1-ligand activity in mouse plasma with a chicken monoclonal antibody for ApoB.

Authors:  Yuko Sato; Norihisa Nishimichi; Atsushi Nakano; Kenji Takikawa; Nobutaka Inoue; Haruo Matsuda; Tatsuya Sawamura
Journal:  Atherosclerosis       Date:  2008-02-12       Impact factor: 5.162

9.  Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain.

Authors:  D R Senger; C A Perruzzi; A Papadopoulos-Sergiou; L Van de Water
Journal:  Mol Biol Cell       Date:  1994-05       Impact factor: 4.138

10.  The integrin alpha 9 beta 1 mediates cell attachment to a non-RGD site in the third fibronectin type III repeat of tenascin.

Authors:  Y Yokosaki; E L Palmer; A L Prieto; K L Crossin; M A Bourdon; R Pytela; D Sheppard
Journal:  J Biol Chem       Date:  1994-10-28       Impact factor: 5.157

View more
  19 in total

1.  Osteopontin is up-regulated and associated with neutrophil and macrophage infiltration in glioblastoma.

Authors:  Nadia A Atai; Manju Bansal; Cheungh Lo; Joost Bosman; Wikky Tigchelaar; Klazien S Bosch; Ard Jonker; Philip C De Witt Hamer; Dirk Troost; Christopher A McCulloch; Vincent Everts; Cornelis J F Van Noorden; Jaro Sodek
Journal:  Immunology       Date:  2010-08-17       Impact factor: 7.397

Review 2.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 3.  Transglutaminase regulation of cell function.

Authors:  Richard L Eckert; Mari T Kaartinen; Maria Nurminskaya; Alexey M Belkin; Gozde Colak; Gail V W Johnson; Kapil Mehta
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

4.  The role of α9β1 integrin and its ligands in the development of autoimmune diseases.

Authors:  Shigeyuki Kon; Toshimitsu Uede
Journal:  J Cell Commun Signal       Date:  2017-10-03       Impact factor: 5.782

5.  Transglutaminase-mediated oligomerization promotes osteoblast adhesive properties of osteopontin and bone sialoprotein.

Authors:  Jennifer Forsprecher; Zhemeng Wang; Harvey A Goldberg; Mari T Kaartinen
Journal:  Cell Adh Migr       Date:  2011-01-01       Impact factor: 3.405

6.  Modulation of infection-mediated migration of neutrophils and CXCR2 trafficking by osteopontin.

Authors:  Rani Singh; Tommy Hui; Aritsune Matsui; Ziyad Allahem; Christopher D Johnston; Montserrat Ruiz-Torruella; Susan R Rittling
Journal:  Immunology       Date:  2016-10-07       Impact factor: 7.397

7.  Osteopontin undergoes polymerization in vivo and gains chemotactic activity for neutrophils mediated by integrin alpha9beta1.

Authors:  Norihisa Nishimichi; Hiromi Hayashita-Kinoh; Chun Chen; Haruo Matsuda; Dean Sheppard; Yasuyuki Yokosaki
Journal:  J Biol Chem       Date:  2011-02-14       Impact factor: 5.157

8.  Polydom/SVEP1 is a ligand for integrin α9β1.

Authors:  Ryoko Sato-Nishiuchi; Itsuko Nakano; Akio Ozawa; Yuya Sato; Makiko Takeichi; Daiji Kiyozumi; Kiyoshi Yamazaki; Teruo Yasunaga; Sugiko Futaki; Kiyotoshi Sekiguchi
Journal:  J Biol Chem       Date:  2012-05-31       Impact factor: 5.157

9.  Osteopontin in Vascular Disease.

Authors:  Zoe Shin Yee Lok; Alicia N Lyle
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

10.  The role of osteopontin in inflammatory processes.

Authors:  Susan Amanda Lund; Cecilia M Giachelli; Marta Scatena
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.